Indonesia Probiotic Food Supplement Market - 2024-2031

Indonesia Probiotic Food Supplement

The Indonesia Probiotic Food Supplement market recorded a value of US$ 104.59 million in 2023 and is expected to reach a value of US$ 137.88 million in 2027, growing at a CAGR of 7.24% during the forecast period (2024-2027).

The demand for probiotic food supplements in Indonesia is growing rapidly, driven by increased health awareness and a focus on gut health. Rising disposable incomes and urbanization are leading to greater adoption of functional foods and dietary supplements, with probiotics recognized for their role in boosting immunity, aiding digestion, and improving overall well-being.

The COVID-19 pandemic further highlighted the importance of preventive healthcare, spurring interest in natural solutions like probiotics. Consumers are gravitating towards natural and organic products, often enriched with local ingredients, reflecting a preference for clean-label and sustainable solutions.

Younger generations, influenced by digital platforms, are more open to experimenting with innovative formats such as gummies, beverages, and sachets. The influence of global trends in personalized nutrition and the growing popularity of synbiotics (probiotics combined with prebiotics) are also shaping the market dynamics. Additionally, government support for improving nutritional standards and combating lifestyle diseases contributes to market growth. Advances in distribution channels, particularly e-commerce, have made probiotic supplements more accessible.

Hence global companies are responding to the growing demand by launching their product in that country. For instance, in July 2024, Zuellig Pharma partnered with Austria-based Institut AllergoSan in a 10-year deal to commercialize the OMNi-BiOTiC probiotic brand in Asia. The partnership includes product registration, sales, marketing, and distribution services. The company announced that OMNi-BiOTiC will launch in Indonesia, the Philippines, and Taiwan in 2025, with expansion to other markets planned.

Market Drivers

Increasing Incidence of Digestive Issues

The increasing incidence of digestive issues is a significant driver for the growth of probiotic food supplements in Indonesia. Rapid urbanization and dietary shifts toward processed and fast foods have contributed to common digestive problems such as bloating, indigestion, and Irritable Bowel Syndrome (IBS). These conditions are exacerbated by stress and sedentary lifestyles, both prevalent in urban areas.

A cross-sectional study at Pelita Harapan University revealed a 25.7% prevalence of Irritable Bowel Syndrome (IBS) among medical students, with women comprising 79.6% of cases. The findings highlight the need for increased awareness and management of IBS among young adults in Indonesia. Probiotic supplements, known for their ability to restore gut flora balance, are gaining popularity as a natural remedy to alleviate these issues. The rising awareness of the gut's role in overall health, including immunity, has further boosted demand.

Lactose intolerance, a widespread condition in Southeast Asia, has also prompted consumers to turn to probiotics for better digestion. Health campaigns and educational efforts by healthcare providers have emphasized the benefits of probiotics in addressing these problems.

Additionally, social media and wellness trends have heightened consumer interest, particularly among younger demographics. The availability of innovative probiotic formats, such as drinks and snacks, has made these products more accessible and appealing. As digestive issues continue to rise, probiotics are increasingly viewed as an essential part of maintaining a healthy lifestyle in Indonesia. Traditional familiarity with fermented foods complements this trend, making probiotics a culturally acceptable choice. The expansion of retail and online channels ensures easy access, further driving market growth.

Government and Health Advocacy

Government and health advocacy play a pivotal role in driving the demand for probiotic food supplements in Indonesia by fostering awareness, promoting preventive healthcare, and supporting the functional food industry. The Indonesian government actively encouraging the consumption of health-promoting foods as part of its broader public health strategy.

National health campaigns highlight the importance of gut health and immunity, positioning probiotics as a valuable addition to daily diets. Regulatory authorities are also simplifying the approval processes for functional foods, including probiotics, ensuring their safety and efficacy while encouraging market growth.

In June 2022, the National Agency for Drug and Food Control (BPOM) hosted a seminar promoting competitive local probiotic products. BPOM head highlighted the growing potential for probiotics beyond food consumption, driven by advancements in science and technology. At a virtual seminar, she emphasized the agency’s support through Regulation Number 17 of 2021, which outlines safety, quality, and benefit standards for probiotic health supplements.

These initiatives are complemented by collaborations with health professionals, who advocate for probiotics as part of holistic health management. The rising availability of probiotics in government-supported healthcare facilities and pharmacies makes them more accessible to the population. Combined with campaigns leveraging social media and traditional media to highlight scientific evidence, these efforts create a favorable environment for probiotic adoption. Together, government and health advocacy are crucial in educating consumers, fostering trust, and driving Indonesia's rapid growth of the probiotic food supplement market.

Market Restraints

Competition from Traditional Remedies

Competition from traditional remedies is a major restraint on the growth of the Indonesian probiotic supplements market. In Indonesia, traditional medicine and herbal remedies have been deeply rooted in the culture for centuries. Fermented foods such as tempeh, a staple in Indonesian cuisine, and beverages like kombucha are naturally rich in probiotics and are widely consumed. These familiar, culturally significant products are trusted by consumers for promoting gut health and overall wellness.

As such, many Indonesians view these traditional remedies as reliable, cost-effective, and more aligned with their dietary habits compared to modern supplements. Probiotic supplements, typically more expensive and less familiar, often struggle to compete with the widespread availability and cultural acceptance of these traditional alternatives.

Moreover, the perception that traditional remedies are safer and more natural further reinforces consumer preference. Many Indonesians remain skeptical about the efficacy of probiotic supplements, especially when they already rely on fermented foods for similar health benefits. This cultural and dietary preference for traditional products limits the willingness of consumers to invest in probiotic supplements, particularly in rural areas where accessibility to supplements may be limited.

Additionally, traditional remedies are often perceived as more authentic and deeply connected to the local way of life, making it difficult for probiotic supplements, which are sometimes seen as foreign or modern, to establish a strong market presence. In this context, the widespread reliance on traditional remedies hampers the acceptance and adoption of probiotic supplements, limiting market expansion and growth.

Market Segment Analysis

The Indonesia probiotic food supplements market is segmented based on ingredient, dosage, application, age and distribution channel.

Rising Awareness of Digestive Health Drives Segment Growth

The gastrointestinal health segment is projected to hold the largest share of the Indonesian probiotic food supplement market. Indonesian consumers are increasingly aware of the importance of maintaining gut health. This is leading to a surge in demand for probiotic food supplements targeting gastrointestinal health, propelling this segment to the forefront of the market.

Common gastrointestinal issues such as bloating, indigestion, and irritable bowel syndrome (IBS) are prevalent in Indonesia. Probiotic supplements offering relief and prevention of these conditions drive substantial growth in this market segment. Clinical studies and research validating the role of probiotics in improving gut health have boosted consumer confidence. This scientific backing further establishes the gastrointestinal health segment as a key pillar in the market.

Sustainability Analysis

Manufacturers in the Indonesian probiotic food supplement market are shifting to biodegradable, recyclable, or reusable packaging materials. This reduces plastic waste, aligns with environmental regulations, and appeals to environmentally conscious consumers. Many brands prioritize sustainably sourced ingredients for their probiotic supplements, such as plant-based cultures and organic substrates. This practice reduces environmental impact and also enhances product appeal in the market, especially among health-conscious buyers.

The Indonesian government’s push for sustainable industrial practices is a major driver for green initiatives in the market. Incentives for using renewable energy and environmentally friendly production methods encourage compliance and innovation among manufacturers. To enhance sustainability, many players in the market are focusing on local sourcing of raw materials. This approach supports the local economy, reduces transportation emissions, and ensures fresh, high-quality ingredients for probiotic food supplements.

Unmet Needs

The Indonesian probiotic supplements market presents significant opportunities for growth, driven by rising health consciousness and an increasing demand for gut health products. However, several unmet needs persist. There is a lack of awareness and education among consumers about the benefits of probiotics beyond digestive health, limiting market potential.

Many consumers are also unaware of the different strains of probiotics and their specific benefits. Moreover, the availability of high-quality, clinically proven probiotic products remains limited, with some products failing to meet local regulatory standards. Consumers in Indonesia seek more tailored solutions to address regional dietary habits and health concerns.

There is also a demand for natural, organic, and plant-based probiotic supplements that align with the increasing trend toward natural health products. In addition, the affordability of probiotics remains a barrier, as high-quality products are often priced out of reach for many Indonesians.

High-quality, clinically validated probiotic products are limited in availability, with some failing to meet local standards. Additionally, there is a growing demand for natural, organic, and plant-based probiotic supplements, in line with health trends. Affordability remains a barrier, as premium products are often costly. Local production is insufficient, with reliance on imported products. Packaging solutions and product formats like sachets or ready-to-drink options are underdeveloped. Tailored probiotic solutions addressing regional dietary habits are also needed.

Packaging and product forms that cater to local preferences, such as sachets or ready-to-drink formats, are also underdeveloped. Lastly, a lack of locally produced probiotic supplements and an over-reliance on imports can hinder market growth. Addressing these gaps offers significant market opportunities.

Competitive Landscape

The major players in the market include PT Galenium Pharmasia, Dexa Group, and PT. Agro Mitra Alimentare, PT. Kalbe Farma Tbk, and SOHO Global Health.

By Ingredient
• Lactobacillus
• Streptococcus
• Bifidobacterium
• Others

By Dosage
• Tablet
• Capsules
• Liquid
• Powder
• Others

o Chewables & Gummies

o Soft Gels

o Others

By Application
• Gastrointestinal Health

o Gut Microbiota/Microbiome Balance

o Digestion

o Constipation

o Bloating

o Diarrhea

o Leaky Gut

o Inflammation

o Immune System

o Others

 Gluten sensitivity

 Abdominal Pain

 GERD/Helicobacter pylori

 Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment

 Gut Flora/Gut Microbiome Restoration

 Others
• Vaginal Health
• Urinary Tract Health

o Kidney Stones

o UTIs

o Others
• Oral Health
• Anti/Healthy Ageing
• Allergies/Asthma
• Bone & Joint Health

o Osteoarthritis

o Osteoporosis/Low Mineral Bone Density

o Inflammation
• Brain/Mental Health

o Sleep

o Cognition

o Mood

o Depression

o Focus
• Cardiovascular Health
• Circulation
• Energy/Fatigue Reduction
• Metabolic Syndrome/Blood Glucose
• Liver Health
• Energy
• Immunity/Respiratory Infections
• Nutrient Absorption
• Skin-Hair-Nails

o Atopic Dermatitis & Eczema

o Acne

o Rosacea

o Hair Growth/Hair Loss

o Skin Microbiome

o Others
• Sports
• Women’s Health

o Fertility

o Menopause

o Pregnancy

o Pcos

o Vaginal Health&Health Vaginal Microbiome

o Vaginal Infections (Bv/Vvc)

o Pregnancy Outcomes

o Others
• Men’s Health & Men's Fertility
• Weight Management
• Pediatric Health

o Colic

o Constipation

o Regurgitation

o Atopic Dermatitis

o Others
• Others

By Age
• Infant
• Children
• Adults
• Seniors

By Distribution Channels
• Supermarkets/Hypermarkets
• Pharmacies and Drug Stores
• Convenience Stores
• Online Retailers
• Other Distribution Channels

Why Purchase the Report?
• To visualize the Indonesia probiotic food supplement market segmentation based on ingredient, dosage, application, age, and distribution channel, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of Indonesia's probiotic food supplement market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The Indonesia probiotic food supplement report would provide approximately 30 tables, 54 figures and 218 pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Ingredient
3.2. Snippet by Dosage
3.3. Snippet by Application
3.4. Snippet by Age
3.5. Snippet by Distribution Channel
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Incidence of Digestive Issues
4.1.1.2. Government and Health Advocacy
4.1.2. Restraints
4.1.2.1. Competition from Traditional Remedies
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. By Ingredient
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
6.1.2. Market Attractiveness Index, By Ingredient
6.2. Lactobacillus*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Streptococcus
6.4. Bifidobacterium
6.5. Others
7. By Dosage
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
7.1.2. Market Attractiveness Index, By Dosage
7.2. Tablet*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Capsules
7.4. Liquid
7.5. Powder
7.6. Others
7.6.1. Chewables & Gummies
7.6.2. Soft Gels
7.6.3. Others
8. Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Gastrointestinal Health*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Gut Microbiota/Microbiome Balance
8.2.4. Digestion
8.2.5. Constipation
8.2.6. Bloating
8.2.7. Diarrhea
8.2.8. Leaky Gut
8.2.9. Inflammation
8.2.10. Immune System
8.2.11. Others
8.2.11.1. Gluten sensitivity
8.2.11.2. Abdominal Pain
8.2.11.3. GERD/Helicobacter pylori
8.2.11.4. Antibiotic-Associate Diarrhea/Post-Antibiotic Treatment
8.2.11.5. Gut Flora/Gut Microbiome Restoration
8.2.11.6. Others
8.3. Vaginal Health
8.4. Urinary Tract Health
8.4.1. Kidney Stones
8.4.2. UTIs
8.4.3. Others
8.5. Oral Health
8.6. Anti/Healthy Ageing
8.7. Allergies/Asthma
8.8. Bone & Joint Health
8.8.1. Osteoarthritis
8.8.2. Osteoporosis/Low Mineral Bone Density
8.8.3. Inflammation
8.9. Brain/Mental Health
8.9.1. Sleep
8.9.2. Cognition
8.9.3. Mood
8.9.4. Depression
8.9.5. Focus
8.10. Cardiovascular Health
8.11. Circulation
8.12. Energy/Fatigue Reduction
8.13. Metabolic Syndrome/Blood Glucose
8.14. Liver Health
8.15. Energy
8.16. Immunity/Respiratory Infections
8.17. Nutrient Absorption
8.18. Skin-Hair-Nails
8.18.1. Atopic Dermatitis & Eczema
8.18.2. Acne
8.18.3. Rosacea
8.18.4. Hair Growth/Hair Loss
8.18.5. Skin Microbiome
8.18.6. Others
8.19. Sports
8.20. Women’s Health
8.20.1. Fertility
8.20.2. Menopause
8.20.3. Pregnancy
8.20.4. PCOS
8.20.5. Vaginal Health & Health Vaginal Microbiome
8.20.6. Vaginal Infections (Bv/Vvc)
8.20.7. Pregnancy Outcomes
8.20.8. Others
8.21. Men’s Health & Men's Fertility
8.22. Weight Management
8.23. Pediatric Health
8.23.1. Colic
8.23.2. Constipation
8.23.3. Regurgitation
8.23.4. Atopic Dermatitis
8.23.5. Others
8.24. Others
9. By Age
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
9.1.2. Market Attractiveness Index, By Age
9.2. Infant*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Children
9.4. Adults
9.5. Seniors
10. By Distribution Channel
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Supermarkets/Hypermarkets*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Pharmacies and Drug Stores
10.4. Convenience Stores
10.5. Online Retailers
10.6. Other Distribution Channels
11. Sustainability Analysis
11.1. Environmental Analysis
11.2. Economic Analysis
11.3. Governance Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. PT Galenium Pharmasia*
13.1.1. Company Overview
13.1.2. Type Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Dexa Group
13.3. PT. Agro Mitra Alimentare
13.4. PT. Kalbe Farma Tbk
13.5. SOHO Global Health (*LIST NOT EXHAUSTIVE)
14. Appendix
14.1. About Us and Services
14.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings